Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06605079

Enhancing Palliative Care in ICU

The aim of this study is to reduce the suffering in intensive care through palliative care consultations.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

ICU General Resuscitation (RES UP), General University hospital, Prague, Czechia

Loading trial locations.

About this study

This project investigates the effectiveness and cost-effectiveness of palliative care consultations in the Intensive care unit. Charité will implement the Working Package 2 "Europe-wide harmonized and recommended palliative care practice for ICU" of the approved HORIZON funding application EPIC, to which this ethics application refers.

An accompanying anonymous employee survey (doctors/nurses) is conducted once in the intervention phase and once in the control phase in all study centers (see secondary endpoints 57-68 and 71).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Patients:

Inclusion criteria

  • Patients in ICU who can give consent and those who can not (via their authorized representative or legal guardian, also possible with delayed consent)
  • From 18 years
  • The leading cause of critical illness is not cancer
  • New admission on the participating ICU > 72h
  • Assessment of the need for palliative care by the in-charge physi-cian of the ICU, because (1) there is a significant disagreement about ICU treatment or (2) because the physician considers ther-apy limitations for the patient or (3) the physician considers a benefit from specialized PC consultation for ICU physician, nurse, or patient or family.

Exclusion criteria

  • Patient is moribund and is expected to die within the next 24h

Study cohort relatives:

Inclusion criteria

  • At least one relative(s) of a patient. This may or may not be the legal representative, depending on national legislation.

Exclusion criteria

  • Refusal by the relative
  • Refusal of the patient to participate in the intervention study
  • <18 years of age

Cohort of employees:

Inclusion criteria

  • Employed on the ITS as a doctor/nurse
  • Employed in the clinical center as a member of the palliative care consultation service

Exclusion criterion Refusal to participate

Treatment and study plan

Complex intervention

Behavioral

A complex intervention is carried out in the intensive care unit. This includes:

  • telemedical consultations by specialized palliative care experts from external institutions for the respective hospital staff
  • the training of hospital staff in the intensive care unit in basic palliative care and
  • the use of checklists for the early identification of eligible patients and the structured recording of palliative care needs.

The efficacy and cost-effectiveness of the complex intervention will be investigated using a controlled clinical trial in a cluster-randomized controlled design. In addition, as part of the multicenter clinical study in WP 2 staff, patients and relatives will also be surveyed.

Routine Treatment

Other

No complex intervention is established, just routine procedures.

Primary outcomes

  1. Length of intensive care stay

    Time frame: During intensive care unit stay, an average of 5 days

    The primary endpoint is the number of days the patient spent in each Intensive Care Unit (ICU) of the index hospital during the first hospitalization.

    For example, if the patient was transferred from the first ICU participating in the EPIC study to another, second ICU within the same hospital, or if the patient was transferred back from a ward to the first ICU, the duration of the secondary ICU is included in the calculation of the primary endpoint.

Secondary outcomes

  1. Costs

    Time frame: During intensive care unit stay, an average of 5 days

    Hospital cost and billing data, data on medical resource consumption combined with data on costs per unit of consumption at hospital level and from external sources, data on intervention costs including staff time for palliative care and related activities, hospital data or national data on salaries of individual professional groups.

  2. Cost effectiveness

    Time frame: During intensive care unit stay, an average of 5 days

    Hospital data on salaries per occupational group

  3. Readmissions to intensive care unit

    Time frame: During hospital stay, an expected average of 8 days

    The readmission rate of patients transferred out of the Intensive care unit

  4. Maximum Sepsis-related organ failure assessment score (SOFA Score) in the intensive care unit

    Time frame: During intensive care unit stay, an average of 5 days

    To evaluate the performance of total maximum sequential organ failure assessment (SOFA) score and a derived measure, delta SOFA (total maximum SOFA score minus admission total SOFA) as a descriptor of multiple organ dysfunction/failure in intensive care.

  5. Palliative Care assessment

    Time frame: During intensive care unit stay, an average of 5 days

    Presence of palliative care assessment performed during study period. The answer to the question: Has the palliative care assessment taken place? Yes/No

  6. Presence of refractory symptoms I

    Time frame: During hospital stay, an expected average of 8 days

    Presence of refractory symptoms I is measured by physical symptoms.

  7. Presence of refractory symptoms II

    Time frame: During intensive care unit stay, an average of 5 days

    Presence of refractory symptoms II is measured by distress of the patient.

  8. Presence of refractory symptoms III

    Time frame: During intensive care unit stay, an average of 5 days

    Presence of refractory symptoms III is measured by distress of the family.

  9. Presence of refractory symptoms IV

    Time frame: During intensive care unit stay, an average of 5 days

    Presence of refractory symptoms IV is measured by social problems of the patient.

  10. Incidence of delirium

    Time frame: During intensive care unit stay, an average of 5 days

    Delirium is measured with validated delirium scores.

  11. Presence and nature of treatment limitations

    Time frame: During intensive care unit stay, an average of 5 days

    Treatment limitation includes limits on the frequency of treatment, number of visits, days of coverage, or other similar limits on the scope or duration of treatment.

  12. Length of hospital stay

    Time frame: During hospital stay, an average of 8 days

    Length of hospital stay is measured from ICU admission to discharge from hospital in days.

  13. Informations on discharge

    Time frame: During hospital stay, an average of 8 days

    Where the patient is discharged to.

  14. Informations on discharge

    Time frame: During intensive care unit stay, an average of 5 days

    Where the patient is discharged to.

  15. Specialized palliative care expert

    Time frame: During hospital stay, an average of 8 days

    Presence of specialized palliative care expert consultation. Answer to the question: Was a specialized palliative care expert consulted? Yes/No Duration of measurement: Until hospital discharge

  16. Mortality

    Time frame: Up to three months

    Intensive care unit, inhouse, until 30 days and until 3 months

  17. Social Status of the patient

    Time frame: Up to three months

    The MacArthur Scale of Subjective Social Status (MacArthur SSS Scale) is a single-item measure that assesses a person's perceived rank relative to others in their group: To score this measure, researchers simply note the number of the rung (1-10) on which the respondent placed their "X."

  18. Place of stay after hospitalization

    Time frame: Up to three months

    Place of stay after hospitalization is measured in questionnaire.

  19. Home care after hospitalization

    Time frame: Up to three months

    Home care after hospitalization is measured in days.

  20. Stress thermometer

    Time frame: Up to three months

    To measure psychological distress the German version of the National Comprehensive Cancer Network Distress Thermometer is used. The scale ranges from 0 (no distress) to 10 (extreme distress) with a cutoff score of 5, indicating a clinically significant level of distress.

  21. Facilitators and barriers to high quality palliative care I

    Time frame: Up to three months

    Facilitators and barriers to high quality palliative care from the perspective of patients.

  22. Facilitators and barriers to high quality palliative care II

    Time frame: Up to three months

    Facilitators and barriers to high quality palliative care from the perspective of relatives.

  23. Symptom management by intensive care staff I

    Time frame: Up to three months

    Symptom management I by intensive care staff from the patient's perspective is measured with a questionnaire.

  24. Symptom management by intensive care staff II

    Time frame: Up to three months

    Symptom management II by intensive care staff from the relative's perspective is measured with a questionnaire.

  25. Treatment evaluation I

    Time frame: Up to three months

    Treatment evaluation I is measured from patients' perspective with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  26. Treatment evaluation II

    Time frame: Up to three months

    Treatment evaluation II is measured from the relatives' (proxy's) perspective with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  27. Evaluation of the provider's question about goals for treatment I

    Time frame: Up to three months

    Evaluation of the provider's question about goals for treatment I from the patients' perspective is measured with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  28. Evaluation of the provider's question about goals for treatment II

    Time frame: Up to three months

    Evaluation of the provider's question about goals for treatment II from the relatives' perspective is measured with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  29. Satisfaction with regard to communication I

    Time frame: Up to three months

    Satisfaction with regard to communication I from the patients' perspective is measured with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  30. Satisfaction with regard to communication II

    Time frame: Up to three months

    Satisfaction with regard to communication II from the relatives' perspective is measured with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  31. Evaluation of the quality of information regarding the treatment I

    Time frame: Up to three months

    Evaluation of the quality of information regarding the treatment from the patients' perspective is measured with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  32. Evaluation of the quality of information regarding the treatment II

    Time frame: Up to three months

    Rating of the quality of information regarding the treatment II from the relatives' perspective is measured with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  33. Suitability of care from the patient's perspective

    Time frame: Up to three months

    Suitability of care from the patient's perspective is measured with a 5-point Likert scale (The choices range from Strongly Agree to Strongly Disagree).

  34. Outpatient resource utilization

    Time frame: Up to three months

    Outpatient resource utilization is measured by the number of outpatient visits.

  35. Utilization of medical resources I

    Time frame: Up to three months

    Utilization of medical resources I is measured in days of mechanical ventilation.

  36. Utilization of medical resources II

    Time frame: Up to three months

    Utilization of medical resources II is measured by Extracorporeal membrane oxygenation Yes/No.

  37. Utilization of medical resources III

    Time frame: Up to three months

    Utilization of medical resources III is measured by dialysis Yes/No.

  38. Utilization of medical resources IV

    Time frame: Up to three months

    Utilization of medical resources IV is measured by other organ replacement therapies. Yes/No.

  39. Medical utilization after discharge from hospital I

    Time frame: During intensive care unit stay, an average of 5 days

    Medical utilization after discharge from hospital I is measured by number and days of re-hospitalizations in days.

  40. Medical utilization after discharge from hospital II

    Time frame: Up to three months

    Medical utilization after discharge from hospital II is measured by days in care institutions in days.

  41. Medical utilization after discharge from hospital III

    Time frame: Up to three months

    Medical utilization after discharge from hospital III is measured by outpatient healthcare encounters in days.

  42. Medical utilization after discharge from hospital IV

    Time frame: Up to three months

    Medical utilization after discharge from hospital IV is measured by use of outpatient nursing services in days.

  43. Medical utilization after discharge from hospital V

    Time frame: Up to three months

    Medical utilization after discharge from hospital V is measured by specialized outpatient palliative care (SAPV) in days.

  44. Patient Health Questionnaire-4 I

    Time frame: Up to three months

    The Patient Health Questionnaire-4 (PHQ-4) I measures anxiety and depression in patients. The PHQ-4 is a four questionnaire answered on a four point Likert-type scale. A score of 3 or more on the depression/anxiety subscale is positive.

  45. Patient Health Questionnaire-4 II

    Time frame: Up to three months

    The Patient Health Questionnaire-4 (PHQ-4) II measures anxiety and depression in relatives. The PHQ-4 is a four questionnaire answered on a four point Likert-type scale. A score of 3 or more on the depression/anxiety subscale is positive.

  46. Health related quality of life I

    Time frame: Up to three months

    Health related quality of life I of the patient is measured with the 5-level EQ-5D version (EQ-5D-5L) from the EuroQol Group.

  47. Question about the opinion of relatives on the unnecessary prolongation of life

    Time frame: Up to three months

    Question about the opinion of relatives on the unnecessary prolongation of life is measured by bipolar Likert scale.

  48. Question about opinion of relatives on discomfort during the final hours before death

    Time frame: Up to three months

    Question about opinion of relatives on discomfort during the final hours before death is measured by bipolar Likert scale.

  49. Question about opinion of relatives on loneliness during dying process.

    Time frame: Up to three months

    Question about opinion of relatives on loneliness during dying process is measured by bipolar Likert scale.

  50. Patient and family friendliness of intensive care unit care I

    Time frame: Up to three months

    Patient and family friendliness of intensive care unit care I assessed by patients, measured with Likert scale/NRS 0-10).

  51. Patient and family friendliness of intensive care unit care II

    Time frame: Up to three months

    Patient and family friendliness of intensive care unit care II assessed by relatives, measured by by Likert scale (too little, just right, too much)/NRS (0-10).

  52. Informal care by relatives I

    Time frame: Up to three months

    Informal care by relatives I is measured by time spent with the patient.

  53. Informal care by relatives II

    Time frame: Up to three months

    Informal care by relatives II is measured by impact on relative's income.

  54. Informal care by relatives III

    Time frame: Up to three months

    Informal care by relatives III is measured by giving up relative´s professional activity.

  55. Informal care by relatives IV

    Time frame: Up to three months

    Informal care by relatives IV is measured by reducing relative's professional activity.

  56. Burnout Assessment Tool (BAT-12)

    Time frame: Up to 34 months.

    Twelve questions from the BAT-12 per employee based on 5 questions is measured with an electronic questionnaire once per intervention and once per control period.

  57. Inappropriate therapy

    Time frame: Up to 34 months

    Perception of inappropriate therapy per employee based on 5 questions to employees is measured with an electronic questionnaire once per intervention and once per control period.

  58. Moral distress

    Time frame: Up to 34 months

    Moral distress per employee is measured with numeric rating scale once per intervention and once per control period.

  59. Implementation of the end-of-life practice

    Time frame: Up to 34 months

    Questions on the current implementation of the end-of-life practice based on 12 questions that are still being developed is measured with an electronic questionnaire once per intervention and once per control period.

  60. Ethical decision-making climate in the intensive care unit

    Time frame: Up to 34 months

    Ethical decision-making climate in the intensive care unit per employee is measured with an electronic questionnaire once per intervention and once per control period.

  61. Questions on the existence of Standard Operating Procedures

    Time frame: Up to 34 months

    Existence of Standard Operating Procedures per employee is measured with 4 questions with an electronic questionnaire once per intervention and once per control period.

  62. Questions about using the ABCDEF bundle

    Time frame: Up to 34 months

    Questions about using the ABCDEF bundle is measured with 11 questions with an electronic questionnaire once per intervention and once per control period.

  63. Questions about supporting measures

    Time frame: Up to 34 months

    Questions about supporting measures is measured with 4 questions with an electronic questionnaire once per intervention and once per control period.

  64. Perception of palliative care and law

    Time frame: Up to 34 months

    Perception of palliative care and law is measured with 4 questions with an electronic questionnaire once per intervention and once per control period.

  65. Question about hurdles to palliative care

    Time frame: Up to 34 months

    Question about hurdles to palliative care in the intensive care medicine is measured with 1 question with an electronic questionnaire once per intervention and once per control period.

  66. Question about supporting factors

    Time frame: Up to 34 months

    Question about supporting factors to palliative care in the intensive care medicine is measured with 1 question with an electronic questionnaire once per intervention and once per control period.

  67. Comments after beginning of the intervention phase

    Time frame: Up to 34 months

    Comments can be made via free text in an electronic questionnaire once per intervention and once per control period.

Other outcomes

  1. Demographic data of the patients

    Time frame: During intensive care unit stay, an average of 5 days

    Demographic data of the patient (age, gender, main diagnosis and reasons for intensive care, insurance status, religion yes/no, highest level of education, employment status, existence of living will, patient power of attorney, chronic conditions) are measured with a questionnaire.

  2. Demographic data of the relatives

    Time frame: Up to three months

    Demographic data of the relative (age, gender, relationship to the patient, representative/guardian, religion yes/no) are measured with a questionnaire.

  3. Employee demographics

    Time frame: Up to 34 months

    Employee demographics (age group, gender, profession, years of professional experience, years and experience in palliative care and/or ethical training, type of intensive care unit) are measured with an electronic questionnaire once per intervention and once per control period.

Study contacts

Contact information is provided by the study sponsor or research team.

Claudia Spies, MD, Prof.

CONTACT

[email protected]

+4930450551102

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Collaborators

  • European Commission

Registry information

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Sep 20, 2024
Registry last updated
Sep 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.